Tissue Factor in health and disease

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 358-372

  Williams, Julie C ^a   Mackman, Nigel ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cardiovascular disease; Diabetes; Infection; Pregnancy; Protease activated receptors; Review; Sickle cell disease; Thrombosis; Tissue Factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FIBRIN; PHOSPHOLIPID ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; SIMVASTATIN; THROMBOPLASTIN;

ACUTE CORONARY SYNDROME; ACUTE GRAFT VERSUS HOST DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIAL INFECTION; BLOOD CLOTTING; BREAST CANCER; CANCER GROWTH; COLORECTAL CANCER; DISEASES; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG TREATMENT FAILURE; EBOLA HEMORRHAGIC FEVER; EMBRYO DEVELOPMENT; ENDOTOXEMIA; FIBRIN DEPOSITION; GLYCEMIC CONTROL; HEALTH; HEMOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; INTRACELLULAR SIGNALING; LUNG METASTASIS; MELANOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PNEUMONIA; POSTPARTUM HEMORRHAGE; PREGNANCY; PROSTATE CANCER; PROTEIN FUNCTION; SEPSIS; SICKLE CELL ANEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VENOUS THROMBOEMBOLISM; VENTILATOR ASSOCIATED PNEUMONIA; CLASSIFICATION; FEMALE; PHYSIOLOGY; REVIEW;

DISEASE; FEMALE; HUMANS; PREGNANCY; THROMBOPLASTIN;

EID: 84860858905     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/383     Document Type: Article

References (161)

1. D. W. Banner, A. D'Arcy, C. Chene, F. K. Winkler, A. Guha, W. H. Konigsberg, Y. Nemerson and D. Kirchhofer: The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature, 380(6569), 41-6 (1996)
2. T. A. Drake, J. H. Morrissey and T. S. Edgington: Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol, 134(5), 1087-97 (1989)
3. R. A. Fleck, L. V. Rao, S. I. Rapaport and N. Varki: Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res, 59(2), 421-37 (1990)
4. M. Hoffman, C. M. Colina, A. G. McDonald, G. M. Arepally, L. Pedersen and D. M. Monroe: Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost, 5(7), 1403-8 (2007)
5. L. Burnier, P. Fontana, B. R. Kwak and A. Angelillo- Scherrer: Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost, 101(3), 439-51 (2009)
6. E. Biro, K. N. Sturk-Maquelin, G. M. Vogel, D. G. Meuleman, M. J. Smit, C. E. Hack, A. Sturk and R. Nieuwland: Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost, 1(12), 2561-8 (2003)
7. V. Y. Bogdanov, V. Balasubramanian, J. Hathcock, O. Vele, M. Lieb and Y. Nemerson: Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med, 9(4), 458-62 (2003)
8. Y. W. van den Berg, L. G. van den Hengel, H. R. Myers, O. Ayachi, E. Jordanova, W. Ruf, C. A. Spek, P. H. Reitsma, V. Y. Bogdanov and H. H. Versteeg: Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A, 106(46), 19497-502 (2009)
9. J. A. Barnes, S. Singh and A. V. Gomes: Protease activated receptors in cardiovascular function and disease. Mol Cell Biochem, 263(1-2), 227-39 (2004)
10. S. R. Coughlin: Protease-activated receptors in vascular biology. Thromb Haemost, 86(1), 298-307 (2001)
11. K. Marutsuka, K. Hatakeyama, Y. Sato, A. Yamashita, A. Sumiyoshi and Y. Asada: Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Res, 107(5), 271-6 (2002)
12. M. Riewald and W. Ruf: Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A, 98(14), 7742-7 (2001)
13. F. Schaffner and W. Ruf: Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromb Vasc Biol, 29(12), 1999-2004 (2009)
14. E. Camerer, W. Huang and S. R. Coughlin: Tissue factor- and factor X-dependent activation of proteaseactivated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A, 97(10), 5255-60 (2000)
15. R. Ramachandran and M. D. Hollenberg: Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol, 153 Suppl 1, S263-82 (2008)
16. T. H. Bugge, Q. Xiao, K. W. Kombrinck, M. J. Flick, K. Holmback, M. J. Danton, M. C. Colbert, D. P. Witte, K. Fujikawa, E. W. Davie and J. L. Degen: Fatal embryonic bleeding events in mice lacking tissue factor, the cellassociated initiator of blood coagulation. Proc Natl Acad Sci U S A, 93(13), 6258-63 (1996)
17. P. Carmeliet, N. Mackman, L. Moons, T. Luther, P. Gressens, I. Van Vlaenderen, H. Demunck, M. Kasper, G. Breier, P. Evrard, M. Muller, W. Risau, T. Edgington and D. Collen: Role of tissue factor in embryonic blood vessel development. Nature, 383(6595), 73-5 (1996)
18. J. R. Toomey, K. E. Kratzer, N. M. Lasky, J. J. Stanton and G. J. Broze, Jr.: Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood, 88(5), 1583-7 (1996)
19. G. C. Parry, J. H. Erlich, P. Carmeliet, T. Luther and N. Mackman: Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest, 101(3), 560-9 (1998)
20. R. Pawlinski, M. Tencati, T. Holscher, B. Pedersen, T. Voet, R. E. Tilley, P. Marynen and N. Mackman: Role of cardiac myocyte tissue factor in heart hemostasis. J Thromb Haemost, 5(8), 1693-700 (2007)
21. R. Pawlinski, J. G. Wang, A. P. Owens, 3rd, J. Williams, S. Antoniak, M. Tencati, T. Luther, J. W. Rowley, E. N. Low, A. S. Weyrich and N. Mackman: Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood, 116(5), 806-14
22. L. Wang, C. Miller, R. F. Swarthout, M. Rao, N. Mackman and M. B. Taubman: Vascular smooth musclederived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood, 113(3), 705-13 (2009)
23. J. Erlich, G. C. Parry, C. Fearns, M. Muller, P. Carmeliet, T. Luther and N. Mackman: Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A, 96(14), 8138-43 (1999)
24. W. P. Faulk, C. A. Labarrere and S. D. Carson: Tissue factor: identification and characterization of cell types in human placentae. Blood, 76(1), 86-96 (1990)
25. G. Girardi: Role of tissue factor in feto-maternal development: a xiphos. J Thromb Haemost
26. N. Mackman: Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol, 24(6), 1015-22 (2004)
27. C. T. Griffin, Y. Srinivasan, Y. W. Zheng, W. Huang and S. R. Coughlin: A role for thrombin receptor signaling in endothelial cells during embryonic development. Science, 293(5535), 1666-70 (2001)
28. B. Isermann, R. Sood, R. Pawlinski, M. Zogg, S. Kalloway, J. L. Degen, N. Mackman and H. Weiler: The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med, 9(3), 331-7 (2003)
29. O. Aras, A. Shet, R. R. Bach, J. L. Hysjulien, A. Slungaard, R. P. Hebbel, G. Escolar, B. Jilma and N. S. Key: Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood, 103(12), 4545-53 (2004)
30. R. F. Franco, E. de Jonge, P. E. Dekkers, J. J. Timmerman, C. A. Spek, S. J. van Deventer, P. van Deursen, L. van Kerkhoff, B. van Gemen, H. ten Cate, T. van der Poll and P. H. Reitsma: The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood, 96(2), 554-9 (2000)
31. T. A. Drake, J. Cheng, A. Chang and F. B. Taylor, Jr.: Expression of tissue factor, thrombomodulin, and Eselectin in baboons with lethal Escherichia coli sepsis. Am J Pathol, 142(5), 1458-70 (1993)
32. C. Carr, G. S. Bild, A. C. Chang, G. T. Peer, M. O. Palmier, R. B. Frazier, M. E. Gustafson, T. C. Wun, A. A. Creasey, L. B. Hinshaw and et al.: Recombinant E. coliderived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gramnegative model of septic shock. Circ Shock, 44(3), 126-37 (1994)
33. A. A. Creasey, A. C. Chang, L. Feigen, T. C. Wun, F. B. Taylor, Jr. and L. B. Hinshaw: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest, 91(6), 2850-60 (1993)
34. E. de Jonge, P. E. Dekkers, A. A. Creasey, C. E. Hack, S. K. Paulson, A. Karim, J. Kesecioglu, M. Levi, S. J. van Deventer and T. van Der Poll: Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood, 95(4), 1124-9 (2000)
35. M. Levi, H. ten Cate, K. A. Bauer, T. van der Poll, T. S. Edgington, H. R. Buller, S. J. van Deventer, C. E. Hack, J. W. ten Cate and R. D. Rosenberg: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest, 93(1), 114-20 (1994)
36. F. B. Taylor, Jr., A. Chang, W. Ruf, J. H. Morrissey, L. Hinshaw, R. Catlett, K. Blick and T. S. Edgington: Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock, 33(3), 127-34 (1991)
37. F. B. Taylor, A. C. Chang, G. Peer, A. Li, M. Ezban and U. Hedner: Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood, 91(5), 1609-15 (1998)
38. R. Pawlinski, B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, W. Boisvert, P. Andrade-Gordon, R. D. Frank and N. Mackman: Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood, 103(4), 1342-7 (2004)
39. E. Abraham, K. Reinhart, S. Opal, I. Demeyer, C. Doig, A. L. Rodriguez, R. Beale, P. Svoboda, P. F. Laterre, S. Simon, B. Light, H. Spapen, J. Stone, A. Seibert, C. Peckelsen, C. De Deyne, R. Postier, V. Pettila, A. Artigas, S. R. Percell, V. Shu, C. Zwingelstein, J. Tobias, L. Poole, J. C. Stolzenbach and A. A. Creasey: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA, 290(2), 238-47 (2003)
40. S. Idell: Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med, 31(4 Suppl), S213-20 (2003)
41. H. Tang, L. Ivanciu, N. Popescu, G. Peer, E. Hack, C. Lupu, F. B. Taylor, Jr. and F. Lupu: Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. Am J Pathol, 171(3), 1066- 77 (2007)
42. J. W. van Till, M. Levi, P. Bresser, M. J. Schultz, D. J. Gouma and M. A. Boermeester: Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis. J Infect Dis, 194(9), 1331-9 (2006)
43. J. A. Bastarache, L. Wang, T. Geiser, Z. Wang, K. H. Albertine, M. A. Matthay and L. B. Ware: The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax, 62(7), 608-16 (2007)
44. A. Gunther, P. Mosavi, S. Heinemann, C. Ruppert, H. Muth, P. Markart, F. Grimminger, D. Walmrath, B. Temmesfeld-Wollbruck and W. Seeger: Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med, 161(2 Pt 1), 454-62 (2000)
45. M. J. Schultz, J. Millo, M. Levi, C. E. Hack, G. J. Weverling, C. S. Garrard and T. van der Poll: Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax, 59(2), 130-5 (2004)
46. G. Choi, M. J. Schultz, J. W. van Till, P. Bresser, J. S. van der Zee, M. A. Boermeester, M. Levi and T. van der Poll: Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J, 24(5), 786-9 (2004)
47. A. W. Rijneveld, S. Weijer, P. Bresser, S. Florquin, G. P. Vlasuk, W. E. Rote, C. A. Spek, P. H. Reitsma, J. S. van der Zee, M. Levi and T. van der Poll: Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med, 34(6), 1725-30 (2006)
48. D. L. Miller, K. Welty-Wolf, M. S. Carraway, M. Ezban, A. Ghio, H. Suliman and C. A. Piantadosi: Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol, 26(6), 650- 8 (2002)
49. J. L. Vincent, A. Artigas, L. C. Petersen and C. Meyer: A multicenter, randomized, double-blind, placebo controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome. Crit Care Med, 37(6), 1874-80 (2009)
50. E. Camerer, I. Cornelissen, H. Kataoka, D. N. Duong, Y. W. Zheng and S. R. Coughlin: Roles of proteaseactivated receptors in a mouse model of endotoxemia. Blood, 107(10), 3912-21 (2006)
51. F. Niessen, F. Schaffner, C. Furlan-Freguia, R. Pawlinski, G. Bhattacharjee, J. Chun, C. K. Derian, P. Andrade-Gordon, H. Rosen and W. Ruf: Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature, 452(7187), 654-8 (2008)
52. N. C. Kaneider, A. J. Leger, A. Agarwal, N. Nguyen, G. Perides, C. Derian, L. Covic and A. Kuliopulos: 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol, 8(12), 1303-12 (2007)
53. X. Su, E. Camerer, J. R. Hamilton, S. R. Coughlin and M. A. Matthay: Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol, 175(4), 2598-605 (2005)
54. X. Su and M. A. Matthay: Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis. Anat Rec (Hoboken), 292(4), 580-6 (2009)
55. T. W. Geisbert, H. A. Young, P. B. Jahrling, K. J. Davis, E. Kagan and L. E. Hensley: Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis, 188(11), 1618-29 (2003)
56. T. W. Geisbert, L. E. Hensley, P. B. Jahrling, T. Larsen, J. B. Geisbert, J. Paragas, H. A. Young, T. M. Fredeking, W. E. Rote and G. P. Vlasuk: Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet, 362(9400), 1953-8 (2003)
57. N. T. Funderburg, E. Mayne, S. F. Sieg, R. Asaad, W. Jiang, M. Kalinowska, A. A. Luciano, W. Stevens, B. Rodriguez, J. M. Brenchley, D. C. Douek and M. M. Lederman: Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood, 115(2), 161-7
58. N. S. Key, G. M. Vercellotti, J. C. Winkelmann, C. F. Moldow, J. L. Goodman, N. L. Esmon, C. T. Esmon and H. S. Jacob: Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A, 87(18), 7095-9 (1990)
59. D. Sosothikul, P. Seksarn, S. Pongsewalak, U. Thisyakorn and J. Lusher: Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost, 97(4), 627-34 (2007)
60. J. N. Wilcox, K. M. Smith, S. M. Schwartz and D. Gordon: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A, 86(8), 2839-43 (1989)
61. Z. Mallat, B. Hugel, J. Ohan, G. Leseche, J. M. Freyssinet and A. Tedgui: Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation, 99(3), 348-53 (1999)
62. K. Brand, C. L. Banka, N. Mackman, R. A. Terkeltaub, S. T. Fan and L. K. Curtiss: Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb, 14(5), 790-7 (1994)
63. T. A. Drake, K. Hannani, H. H. Fei, S. Lavi and J. A. Berliner: Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol, 138(3), 601-7 (1991)
64. T. Kaneko, H. Wada, Y. Wakita, K. Minamikawa, T. Nakase, Y. Mori, K. Deguchi and S. Shirakawa: Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins. Blood Coagul Fibrinolysis, 5(3), 385-92 (1994)
65. P. Lesnik, M. Rouis, S. Skarlatos, H. S. Kruth and M. J. Chapman: Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A, 89(21), 10370-4 (1992)
66. P. Schuff-Werner, G. Claus, V. W. Armstrong, H. Kostering and D. Seidel: Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis, 78(2-3), 109-12 (1989)
67. E. Tremoli, M. Camera, P. Maderna, L. Sironi, L. Prati, S. Colli, F. Piovella, F. Bernini, A. Corsini and L. Mussoni: Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon. Arterioscler Thromb, 13(3), 338-46 (1993)
68. J. R. Weis, R. E. Pitas, B. D. Wilson and G. M. Rodgers: Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J, 5(10), 2459-65 (1991)
69. S. Colli, M. Lalli, P. Rise, L. Mussoni, S. Eligini, C. Galli and E. Tremoli: Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells. Thromb Haemost, 81(4), 576- 81 (1999)
70. K. Kato, Y. A. Elsayed, M. Namoto, K. Nakagawa and K. Sueishi: Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res, 82(4), 335-47 (1996)
71. M. B. Taubman, J. D. Marmur, C. L. Rosenfield, A. Guha, S. Nichtberger and Y. Nemerson: Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest, 91(2), 547-52 (1993)
72. A. D. Schecter, P. L. Giesen, O. Taby, C. L. Rosenfield, M. Rossikhina, B. S. Fyfe, D. S. Kohtz, J. T. Fallon, Y. Nemerson and M. B. Taubman: Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest, 100(9), 2276-85 (1997)
73. M. Camera, P. L. Giesen, J. Fallon, B. M. Aufiero, M. Taubman, E. Tremoli and Y. Nemerson: Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol, 19(3), 531-7 (1999)
74. R. J. Westrick, P. F. Bodary, Z. Xu, Y. C. Shen, G. J. Broze and D. T. Eitzman: Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation, 103(25), 3044-6 (2001)
75. S. Pan, T. A. White, T. A. Witt, A. Chiriac, C. S. Mueske and R. D. Simari: Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development. Circ Res, 105(7), 713-20, 8 p following 720 (2009)
76. R. E. Tilley, B. Pedersen, R. Pawlinski, Y. Sato, J. H. Erlich, Y. Shen, S. Day, Y. Huang, D. T. Eitzman, W. A. Boisvert, L. K. Curtiss, W. P. Fay and N. Mackman: Atherosclerosis in mice is not affected by a reduction in tissue factor expression. Arterioscler Thromb Vasc Biol, 26(3), 555- 62 (2006)
77. R. T. Pyo, Y. Sato, N. Mackman and M. B. Taubman: Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration. Thromb Haemost, 92(3), 451-8 (2004)
78. L. A. Harker, S. R. Hanson, J. N. Wilcox and A. B. Kelly: Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis, 26 Suppl 1, 76-82 (1996)
79. R. Singh, S. Pan, C. S. Mueske, T. A. Witt, L. S. Kleppe, T. E. Peterson, N. M. Caplice and R. D. Simari: Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling. Thromb Haemost, 89(4), 747-51 (2003)
80. J. Bis, J. Vojacek, J. Dusek, M. Pecka, V. Palicka, J. Stasek and J. Maly: Time-course of tissue factor plasma level in patients with acute coronary syndrome. Physiol Res, 58(5), 661-7 (2009)
81. P. E. Morange, S. Blankenberg, M. C. Alessi, C. Bickel, H. J. Rupprecht, R. Schnabel, E. Lubos, T. Munzel, D. Peetz, V. Nicaud, I. Juhan-Vague and L. Tiret: Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost, 5(3), 475-82 (2007)
82. N. Yamamoto, H. Ogawa, S. Oshima, H. Soejima, H. Fujii, K. Misumi, K. Takazoe, Y. Mizuno, K. Noda, T. Saito, I. Tsuji, K. Kumeda, S. Nakamura and H. Yasue: The effect of heparin on tissue factor and tissue factor pathway inhibitor in patients with acute myocardial infarction. Int J Cardiol, 75(2-3), 267-74 (2000)
83. A. Malarstig, T. Tenno, N. Johnston, B. Lagerqvist, T. Axelsson, A. C. Syvanen, L. Wallentin and A. Siegbahn: Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol, 25(12), 2667-72 (2005)
84. M. Brambilla, M. Camera, D. Colnago, G. Marenzi, M. De Metrio, P. L. Giesen, A. Balduini, F. Veglia, K. Gertow, P. Biglioli and E. Tremoli: Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol, 28(5), 947-53 (2008)
85. A. P. Owens, 3rd, R. E. Temel, D. A. Barcel, S. M. Marshall, A. L. McDaniel and N. Mackman: Hyperlipidemia Increases Microparticle Tissue Factor and the Activation of Coagulation: A Tale of Mice and Monkeys. Circulation, 122, A20151 (2010)
86. J. H. Erlich, E. M. Boyle, J. Labriola, J. C. Kovacich, R. A. Santucci, C. Fearns, E. N. Morgan, W. Yun, T. Luther, O. Kojikawa, T. R. Martin, T. H. Pohlman, E. D. Verrier and N. Mackman: Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol, 157(6), 1849-62 (2000)
87. P. Golino, M. Ragni, P. Cirillo, V. E. Avvedimento, A. Feliciello, N. Esposito, A. Scognamiglio, B. Trimarco, G. Iaccarino, M. Condorelli, M. Chiariello and G. Ambrosio: Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med, 2(1), 35-40 (1996)
88. S. T. Loubele, C. A. Spek, P. Leenders, R. van Oerle, H. L. Aberson, D. van der Voort, K. Hamulyak, L. C. Petersen, H. M. Spronk and H. ten Cate: Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in mice. J Thromb Haemost, 7(2), 290-8 (2009)
89. S. M. Day, J. L. Reeve, B. Pedersen, D. M. Farris, D. D. Myers, M. Im, T. W. Wakefield, N. Mackman and W. P. Fay: Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood, 105(1), 192-8 (2005)
90. A. B. Pawashe, P. Golino, G. Ambrosio, F. Migliaccio, M. Ragni, I. Pascucci, M. Chiariello, R. Bach, A. Garen, W. K. Konigsberg and et al.: A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res, 74(1), 56-63 (1994)
91. M. Roque, E. D. Reis, V. Fuster, A. Padurean, J. T. Fallon, M. B. Taubman, J. H. Chesebro and J. J. Badimon: Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. J Am Coll Cardiol, 36(7), 2303-10 (2000)
92. C. M. Speidel, J. D. Thornton, Y. Y. Meng, P. R. Eisenberg, T. S. Edgington and D. R. Abendschein: Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa. Coron Artery Dis, 7(1), 57-62 (1996)
93. A. Y. Lee and G. P. Vlasuk: Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor. J Intern Med, 254(4), 313-21 (2003)
94. G. P. Vlasuk, A. Bradbury, L. Lopez-Kinninger, S. Colon, P. W. Bergum, S. Maki and W. E. Rote: Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X. Thromb Haemost, 90(5), 803-12 (2003)
95. J. Himber, D. Kling, J. T. Fallon, Y. Nemerson and M. A. Riederer: In situ localization of tissue factor in human thrombi. Blood, 99(11), 4249-50 (2002)
96. Y. Kamikura, H. Wada, T. Nobori, T. Kobayashi, T. Sase, M. Nishikawa, K. Ishikura, N. Yamada, Y. Abe, J. Nishioka, T. Nakano and H. Shiku: Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism. Thromb Res, 116(4), 307-12 (2005)
97. J. Zhou, L. May, P. Liao, P. L. Gross and J. I. Weitz: Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol, 29(6), 863-9 (2009)
98. F. R. Rickles, G. A. Hair, R. A. Zeff, E. Lee and R. D. Bona: Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost, 74(1), 391-5 (1995)
99. J. L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, J. I. Weitz, B. L. Coomber, N. Mackman and J. W. Rak: Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood, 105(4), 1734-41 (2005)
100. M. Davila, A. Amirkhosravi, E. Coll, H. Desai, L. Robles, J. Colon, C. H. Baker and J. L. Francis: Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost, 6(9), 1517-24 (2008)
101. J. A. Heit: Cancer and venous thromboembolism: scope of the problem. Cancer Control, 12 Suppl 1, 5-10 (2005)
102. L. L. Swystun, L. Y. Shin, S. Beaudin and P. C. Liaw: Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes. J Thromb Haemost, 7(4), 619-26 (2009)
103. M. E. Tesselaar, F. P. Romijn, I. K. Van Der Linden, F. A. Prins, R. M. Bertina and S. Osanto: Microparticleassociated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost, 5(3), 520-7 (2007)
104. K. Haubold, M. Rink, B. Spath, M. Friedrich, F. K. Chun, G. Marx, A. Amirkhosravi, J. L. Francis, C. Bokemeyer, B. Eifrig and F. Langer: Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost, 101(6), 1147-55 (2009)
105. G. Hron, M. Kollars, H. Weber, V. Sagaster, P. Quehenberger, S. Eichinger, P. A. Kyrle and A. Weltermann: Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost, 97(1), 119-23 (2007)
106. M. E. Tesselaar, F. P. Romijn, I. K. van der Linden, R. M. Bertina and S. Osanto: Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J Thromb Haemost, 7(8), 1421-3 (2009)
107. D. A. Manly, J. Wang, S. L. Glover, R. Kasthuri, H. A. Liebman, N. S. Key and N. Mackman: Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res, 125(6), 511-2
108. A. A. Khorana, C. W. Francis, K. E. Menzies, J. G. Wang, O. Hyrien, J. Hathcock, N. Mackman and M. B. Taubman: Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost, 6(11), 1983-5 (2008)
109. A. Amirkhosravi, T. Meyer, J. Y. Chang, M. Amaya, F. Siddiqui, H. Desai and J. L. Francis: Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost, 87(6), 930-6 (2002)
110. B. M. Mueller, R. A. Reisfeld, T. S. Edgington and W. Ruf: Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A, 89(24), 11832-6 (1992)
111. B. M. Mueller and W. Ruf: Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest, 101(7), 1372-8 (1998)
112. E. Camerer, A. A. Qazi, D. N. Duong, I. Cornelissen, R. Advincula and S. R. Coughlin: Platelets, proteaseactivated receptors, and fibrinogen in hematogenous metastasis. Blood, 104(2), 397-401 (2004)
113. J. S. Palumbo, K. E. Talmage, J. V. Massari, C. M. La Jeunesse, M. J. Flick, K. W. Kombrinck, Z. Hu, K. A. Barney and J. L. Degen: Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood, 110(1), 133-41 (2007)
114. A. K. Kakkar, V. Chinswangwatanakul, N. R. Lemoine, S. Tebbutt and R. C. Williamson: Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma. Br J Surg, 86(7), 890-4 (1999)
115. Y. Zhang, Y. Deng, T. Luther, M. Muller, R. Ziegler, R. Waldherr, D. M. Stern and P. P. Nawroth: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest, 94(3), 1320-7 (1994)
116. J. Yu, L. May, C. Milsom, G. M. Anderson, J. I. Weitz, J. P. Luyendyk, G. Broze, N. Mackman and J. Rak: Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol, 28(11), 1975-81 (2008)
117. T. A. Hembrough, G. M. Swartz, A. Papathanassiu, G. P. Vlasuk, W. E. Rote, S. J. Green and V. S. Pribluda: Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res, 63(11), 2997-3000 (2003)
118. C. C. Milsom, J. L. Yu, N. Mackman, J. Micallef, G. M. Anderson, A. Guha and J. W. Rak: Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res, 68(24), 10068-76 (2008)
119. H. H. Versteeg, F. Schaffner, M. Kerver, L. G. Ellies, P. Andrade-Gordon, B. M. Mueller and W. Ruf: Proteaseactivated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res, 68(17), 7219-27 (2008)
120. H. H. Versteeg, F. Schaffner, M. Kerver, H. H. Petersen, J. Ahamed, B. Felding-Habermann, Y. Takada, B. M. Mueller and W. Ruf: Inhibition of tissue factor signaling suppresses tumor growth. Blood, 111(1), 190-9 (2008)
121. K. S. Ginsburg, M. H. Liang, L. Newcomer, S. Z. Goldhaber, P. H. Schur, C. H. Hennekens and M. J. Stampfer: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med, 117(12), 997-1002 (1992)
122. M. Blank, J. Cohen, V. Toder and Y. Shoenfeld: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci U S A, 88(8), 3069-73 (1991)
123. S. S. Pierangeli, J. H. Barker, D. Stikovac, D. Ackerman, G. Anderson, J. Barquinero, R. Acland and E. N. Harris: Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost, 71(5), 670-4 (1994)
124. M. J. Cuadrado, C. Lopez-Pedrera, M. A. Khamashta, M. T. Camps, F. Tinahones, A. Torres, G. R. Hughes and F. Velasco: Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum, 40(5), 834-41 (1997)
125. P. M. Dobado-Berrios, C. Lopez-Pedrera, F. Velasco, M. A. Aguirre, A. Torres and M. J. Cuadrado: Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost, 82(6), 1578-82 (1999)
126. J. C. Reverter, D. Tassies, J. Font, J. Monteagudo, G. Escolar, M. Ingelmo and A. Ordinas: Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s. Arterioscler Thromb Vasc Biol, 16(11), 1319-26 (1996)
127. C. Lopez-Pedrera, P. Buendia, N. Barbarroja, E. Siendones, F. Velasco and M. J. Cuadrado: Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells. Clin Appl Thromb Hemost, 12(1), 41-5 (2006)
128. H. Zhou, A. S. Wolberg and R. A. Roubey: Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood, 104(8), 2353-8 (2004)
129. G. Montiel-Manzano, Z. Romay-Penabad, E. Papalardo de Martinez, L. A. Meillon-Garcia, E. Garcia- Latorre, E. Reyes-Maldonado and S. S. Pierangeli: In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies. Ann N Y Acad Sci, 1108, 540-53 (2007)
130. A. V. Kinev and R. A. Roubey: Tissue factor in the antiphospholipid syndrome. Lupus, 17(10), 952-8 (2008)
131. K. Ritis, M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, P. Magotti, S. Rafail, G. Kartalis, P. Sideras and J. D. Lambris: A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol, 177(7), 4794-802 (2006)
132. B. Osterud: Tissue factor in neutrophils: no. J Thromb Haemost, 2(2), 218-20 (2004)
133. G. Girardi, J. Berman, P. Redecha, L. Spruce, J. M. Thurman, D. Kraus, T. J. Hollmann, P. Casali, M. C. Caroll, R. A. Wetsel, J. D. Lambris, V. M. Holers and J. E. Salmon: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest, 112(11), 1644-54 (2003)
134. P. Redecha, C. W. Franzke, W. Ruf, N. Mackman and G. Girardi: Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest, 118(10), 3453-61 (2008)
135. G. Girardi: Pravastatin prevents miscarriages in antiphospholipid antibody-treated mice. J Reprod Immunol, 82(2), 126-31 (2009)
136. A. S. Shet, O. Aras, K. Gupta, M. J. Hass, D. J. Rausch, N. Saba, L. Koopmeiners, N. S. Key and R. P. Hebbel: Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood, 102(7), 2678-83 (2003)
137. N. S. Key, A. Slungaard, L. Dandelet, S. C. Nelson, C. Moertel, L. A. Styles, F. A. Kuypers and R. R. Bach: Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood, 91(11), 4216-23 (1998)
138. A. Solovey, L. Gui, N. S. Key and R. P. Hebbel: Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest, 101(9), 1899-904 (1998)
139. A. Solovey, R. Kollander, L. C. Milbauer, F. Abdulla, Y. Chen, R. J. Kelm, Jr. and R. P. Hebbel: Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse. Am J Hematol, 85(1), 41-5
140. A. Solovey, R. Kollander, A. Shet, L. C. Milbauer, S. Choong, A. Panoskaltsis-Mortari, B. R. Blazar, R. J. Kelm, Jr. and R. P. Hebbel: Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood, 104(3), 840-6 (2004)
141. M. E. Carr: Diabetes mellitus: a hypercoagulable state. J Diabetes Complications, 15(1), 44-54 (2001)
142. V. Y. Bogdanov and B. Osterud: Cardiovascular complications of diabetes mellitus: The Tissue Factor perspective. Thromb Res, 125(2), 112-8
143. A. Vambergue, L. Rugeri, V. Gaveriaux, P. Devos, A. Martin, C. Fermon, P. Fontaine and B. Jude: Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age. Thromb Res, 101(5), 367-75 (2001)
144. F. Khechai, V. Ollivier, F. Bridey, M. Amar, J. Hakim and D. de Prost: Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler Thromb Vasc Biol, 17(11), 2885-90 (1997)
145. A. E. Buchs, A. Kornberg, M. Zahavi, D. Aharoni, C. Zarfati and M. J. Rapoport: Increased expression of tissue factor and receptor for advanced glycation end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus with vascular complications. Exp Diabesity Res, 5(2), 163-9 (2004)
146. A. Sambola, J. Osende, J. Hathcock, M. Degen, Y. Nemerson, V. Fuster, J. Crandall and J. J. Badimon: Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation, 107(7), 973-7 (2003)
147. M. Diamant, R. Nieuwland, R. F. Pablo, A. Sturk, J. W. Smit and J. K. Radder: Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation, 106(19), 2442-7 (2002)
148. V. R. Vaidyula, G. J. Criner, C. Grabianowski and A. K. Rao: Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res, 124(3), 259-61 (2009)
149. F. Tacke, P. Schoffski, C. Trautwein, M. P. Manns, A. Ganser and M. von Depka: Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease. Blood Coagul Fibrinolysis, 12(7), 539-45 (2001)
150. W. Miehsler, W. Reinisch, E. Valic, W. Osterode, W. Tillinger, T. Feichtenschlager, J. Grisar, K. Machold, S. Scholz, H. Vogelsang and G. Novacek: Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut, 53(4), 542-8 (2004)
151. A. Undas, D. Owczarek, M. Gissel, K. Salapa, K. G. Mann and S. Butenas: Activated factor XI and tissue factor in inflammatory bowel disease. Inflamm Bowel Dis, 16(9), 1447- 8
152. C. Anthoni, J. Russell, K. C. Wood, K. Y. Stokes, T. Vowinkel, D. Kirchhofer and D. N. Granger: Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med, 204(7), 1595-601 (2007)
153. J. Hao, W. Li, P. Zou, Q. Li, L. Xia and Y. You: Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. J Huazhong Univ Sci Technolog Med Sci, 29(6), 697-700 (2009)
154. S. Colli, S. Eligini, M. Lalli, M. Camera, R. Paoletti and E. Tremoli: Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol, 17(2), 265-72 (1997)
155. D. Ferro, S. Basili, C. Alessandri, D. Cara and F. Violi: Inhibition of tissue-factor-mediated thrombin generation by simvastatin. Atherosclerosis, 149(1), 111-6 (2000)
156. S. Steiner, W. S. Speidl, J. Pleiner, D. Seidinger, G. Zorn, C. Kaun, J. Wojta, K. Huber, E. Minar, M. Wolzt and C. W. Kopp: Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation, 111(14), 1841-6 (2005)
157. M. Eto, T. Kozai, F. Cosentino, H. Joch and T. F. Luscher: Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation, 105(15), 1756-9 (2002)
158. H. Holschermann, D. Schuster, B. Parviz, W. Haberbosch, H. Tillmanns and H. Muth: Statins prevent NF-kappaB transactivation independently of the IKKpathway in human endothelial cells. Atherosclerosis, 185(2), 240-5 (2006)
159. T. Ishibashi, T. Sakamoto, H. Ohkawara, K. Nagata, K. Sugimoto, S. Sakurada, N. Sugimoto, A. Watanabe, K. Yokoyama, N. Sakamoto, M. Kurabayashi, Y. Takuwa and Y. Maruyama: Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells. Arterioscler Thromb Vasc Biol, 23(4), 681-7 (2003)
160. N. Mackman: Regulation of the tissue factor gene. Thromb Haemost, 78(1), 747-54 (1997)
161. K. Nagata, T. Ishibashi, T. Sakamoto, H. Ohkawara, J. Shindo, K. Yokoyama, K. Sugimoto, S. Sakurada, Y. Takuwa, S. Nakamura, T. Teramoto and Y. Maruyama: Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes. Atherosclerosis, 163(1), 39-47 (2002)